Teva gives up on turning Nuvigil into an antidepressant

Teva Pharmaceutical Industries ($TEVA) scrapped its plans to develop Nuvigil as a treatment for depression. The drug, originally approved to treat sleep apnea, had failed another Phase III trial. Report